Cargando…
CD134/CD137 Dual Costimulation-Elicited IFN-γ Maximizes Effector T Cell Function but Limits Treg Expansion
T cell tolerance to tumor antigens represents a major hurdle in generating tumor immunity. Combined administration of agonistic monoclonal antibodies to the costimulatory receptors CD134 plus CD137 can program T cells responding to tolerogenic antigen to undergo expansion and effector T cell differe...
Autores principales: | Rose, Marie-Clare St., Taylor, Roslyn A., Bandyopadhyay, Suman, Qui, Harry Z., Hagymasi, Adam T., Vella, Anthony T., Adler, Adam J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570742/ https://www.ncbi.nlm.nih.gov/pubmed/23295363 http://dx.doi.org/10.1038/icb.2012.74 |
Ejemplares similares
-
A mathematical model of combined CD8 T cell costimulation by 4-1BB (CD137) and OX40 (CD134) receptors
por: Konstorum, Anna, et al.
Publicado: (2019) -
Betting on improved cancer immunotherapy by doubling down on CD134 and CD137 co-stimulation
por: Adler, Adam J., et al.
Publicado: (2013) -
Hypoxia-induced soluble CD137 in malignant cells blocks CD137L-costimulation as an immune escape mechanism
por: Labiano, Sara, et al.
Publicado: (2014) -
Chronic CD27-CD70 costimulation promotes type 1-specific polarization of effector Tregs
por: Bowakim-Anta, Natalia, et al.
Publicado: (2023) -
Evaluating the glycolytic potential of mouse costimulated effector CD8(+) T cells ex vivo
por: Agliano, Federica, et al.
Publicado: (2022)